1. Home
  2. WLFC vs AVXL Comparison

WLFC vs AVXL Comparison

Compare WLFC & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WLFC
  • AVXL
  • Stock Information
  • Founded
  • WLFC 1985
  • AVXL 2004
  • Country
  • WLFC United States
  • AVXL United States
  • Employees
  • WLFC N/A
  • AVXL N/A
  • Industry
  • WLFC Industrial Specialties
  • AVXL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • WLFC Consumer Discretionary
  • AVXL Health Care
  • Exchange
  • WLFC Nasdaq
  • AVXL Nasdaq
  • Market Cap
  • WLFC 1.0B
  • AVXL 956.7M
  • IPO Year
  • WLFC 1996
  • AVXL N/A
  • Fundamental
  • Price
  • WLFC $131.61
  • AVXL $8.02
  • Analyst Decision
  • WLFC
  • AVXL Strong Buy
  • Analyst Count
  • WLFC 0
  • AVXL 3
  • Target Price
  • WLFC N/A
  • AVXL $44.00
  • AVG Volume (30 Days)
  • WLFC 47.6K
  • AVXL 1.4M
  • Earning Date
  • WLFC 11-04-2025
  • AVXL 08-12-2025
  • Dividend Yield
  • WLFC 0.76%
  • AVXL N/A
  • EPS Growth
  • WLFC 30.03
  • AVXL N/A
  • EPS
  • WLFC 16.84
  • AVXL N/A
  • Revenue
  • WLFC $637,163,000.00
  • AVXL N/A
  • Revenue This Year
  • WLFC $16.17
  • AVXL N/A
  • Revenue Next Year
  • WLFC $4.88
  • AVXL N/A
  • P/E Ratio
  • WLFC $7.82
  • AVXL N/A
  • Revenue Growth
  • WLFC 32.40
  • AVXL N/A
  • 52 Week Low
  • WLFC $124.90
  • AVXL $5.62
  • 52 Week High
  • WLFC $235.43
  • AVXL $14.44
  • Technical
  • Relative Strength Index (RSI)
  • WLFC 43.47
  • AVXL 34.10
  • Support Level
  • WLFC $129.39
  • AVXL $8.41
  • Resistance Level
  • WLFC $133.50
  • AVXL $9.50
  • Average True Range (ATR)
  • WLFC 3.70
  • AVXL 0.51
  • MACD
  • WLFC 0.43
  • AVXL -0.11
  • Stochastic Oscillator
  • WLFC 51.98
  • AVXL 8.51

About WLFC Willis Lease Finance Corporation

Willis Lease Finance Corp, with its subsidiaries, is a lessor and servicer of commercial aircraft and aircraft engines. The company has two reportable business segments, which include Leasing and Related Operations and Spare Parts Sales. A majority of its revenue is generated from the Leasing and Related Operations segment, which involves acquiring and leasing, under operating leases, commercial aircraft, aircraft engines, and other aircraft equipment and the selective purchase and resale of commercial aircraft engines, aircraft equipment, and other related businesses. Geographically, the company derives maximum revenue from the United States, followed by Europe, Asia-Pacific (excluding India), India, South America, Canada, Central America, and the Middle East.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.

Share on Social Networks: